News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Medicare Drug Coverage Is Often Inadequate—Here’s Why
American healthcare spending dwarfs that of every other wealthy country, and the cost of Medicare, alone, threatens the fiscal viability of the federal government. If insurers do not try to hold down the cost of American medical care, who will?
Adult Swim’s Common Side Effects Show Pitfalls of Medicare Advantage
The show follows once-separated high school friends Marshall, a mycologist, and Frances, the executive assistant to a pharmaceutical executive, who reconnect after Marshall begins peppering Frances’ boss with questions during a public event announcing a new drug the pharmaceutical company is launching.
Assistant Attorney General Jonathan Kanter Delivers Remarks on the Platformization of Health care
“In 2010, the big insurers promoted the narrative that single payer was a threat to Americans. Nearly 15 years later, we may well be accelerating the march to single payer, just not the kind anyone imagined in 2010, or wants today.
The moment for this discussion is now and the timing is urgent.” —AAG Jonathan Kanter
‘Ghost network’ of US healthcare providers amounts to fraud, lawsuit says
Class action finds ‘staggering’ cases of people struggling to find mental health care coinciding with mental health crisis
Medicare patient wrongly sent to collections in dispute between two UnitedHealth Group entities
The Minnesota-based insurer said he owed $275. The surgery center in St. Cloud wanted another $3,300. UnitedHealth owns both and is now apologizing.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.